An estimated 20,000 to 30,000 cases of imported malaria are annually diagnosed in industrialised countries. Some 700 of them concern Swiss travellers and foreign guests. Exposure prophylaxis and chemoprophylaxis for high risk destinations lower the risk of malarial disease. The latter is defined as regular intake of antimalarial drugs in subtherapeutic dosage in order to suppress the development of clinical disease. Drugs are usually taken from one week before travel until four weeks after return from an endemic area. Mefloquine, doxycycline, chloroquine plus proguanil, and presumably soon also atovaquone plus proguanil are available in Switzerland for chemoprophylaxis
Abstract. Mefloquine has been licensed and registered in Japan for chemoprophylaxis against malaria ...
Malaria, a disease caused by the plasmodium parasite and spread by the female anopheles condition is...
Since its introduction to the market in 1985, mefloquine has been used for malaria chemoprophylaxis ...
An estimated 20,000 to 30,000 cases of imported malaria are annually diagnosed in industrialised cou...
There are several possible malaria prevention strategies for travellers. In Switzerland, chemoprophy...
The prevention of malaria in travelers with the use of antimalarials often occurs in connection with...
For successful malaria prophylaxis, future travelers need to be informed about the risks of infectio...
Despite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has domina...
Physicians advising travelers going to parts of the world where malaria transmission occurs should r...
Despite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has domina...
Each year almost 50 million travelers visit malaria endemic areas and 10,000 - 30,000 of them get il...
Currently available medications for malaria chemoprophylaxis are efficacious but the problems of pat...
Abstract. Although efficacious forms of malaria chemoprophylaxis currently exist, many travelers to ...
SummaryDespite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has...
Malaria prevention in travelers to endemic areas remains dependent principally on chemoprophylaxis. ...
Abstract. Mefloquine has been licensed and registered in Japan for chemoprophylaxis against malaria ...
Malaria, a disease caused by the plasmodium parasite and spread by the female anopheles condition is...
Since its introduction to the market in 1985, mefloquine has been used for malaria chemoprophylaxis ...
An estimated 20,000 to 30,000 cases of imported malaria are annually diagnosed in industrialised cou...
There are several possible malaria prevention strategies for travellers. In Switzerland, chemoprophy...
The prevention of malaria in travelers with the use of antimalarials often occurs in connection with...
For successful malaria prophylaxis, future travelers need to be informed about the risks of infectio...
Despite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has domina...
Physicians advising travelers going to parts of the world where malaria transmission occurs should r...
Despite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has domina...
Each year almost 50 million travelers visit malaria endemic areas and 10,000 - 30,000 of them get il...
Currently available medications for malaria chemoprophylaxis are efficacious but the problems of pat...
Abstract. Although efficacious forms of malaria chemoprophylaxis currently exist, many travelers to ...
SummaryDespite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has...
Malaria prevention in travelers to endemic areas remains dependent principally on chemoprophylaxis. ...
Abstract. Mefloquine has been licensed and registered in Japan for chemoprophylaxis against malaria ...
Malaria, a disease caused by the plasmodium parasite and spread by the female anopheles condition is...
Since its introduction to the market in 1985, mefloquine has been used for malaria chemoprophylaxis ...